High materiality7/10
Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raises ASND target to $333; current price around $246.23, implying meaningful upside.
- Jefferies raises ASND PT to $333; price $246.23.
Key facts
- 01
Target: $333
- 02
Posted price: $246.23
- 03
Analyst firm: Jefferies
- 04
Analyst: Kelly Shi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.